Clinical Trial

Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis Management

Study acronym: amniOST
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to demonstrate, during the first standard surgical management of patients with stage II MRONJ, the effect of the implantation of a cryopreserved hAM on the maxillomandibular bone, on the healing of the oral mucosa.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-12-21; most recent amendment 2024-09-05.
Status change: Active, Not Recruiting → Recruiting 2023-10-11
Trial Details
NCT Number NCT05664815
Lead Sponsor Centre Hospitalier Universitaire de Besancon
Conditions Osteonecrosis Due to Drugs, Jaw
Enrollment 66 participants
Start Date 2023-09-22
Primary Completion 2025-09 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2024-09-19